These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 9453954)
1. [Antibodies as specific tumor therapy agents. Wishful thinking or reality?]. Gramatzki M; Valerius T Internist (Berl); 1997 Nov; 38(11):1055-62. PubMed ID: 9453954 [No Abstract] [Full Text] [Related]
2. The use of monoclonal antibody immunoconjugates in cancer therapy. Pietersz GA; Krauer K; McKenzie IF Adv Exp Med Biol; 1994; 353():169-79. PubMed ID: 7985535 [No Abstract] [Full Text] [Related]
3. Improving the efficacy of antibody-based cancer therapies. Carter P Nat Rev Cancer; 2001 Nov; 1(2):118-29. PubMed ID: 11905803 [TBL] [Abstract][Full Text] [Related]
4. Using antibodies to target cancer therapeutics. Goldenberg DM; Sharkey RM Expert Opin Biol Ther; 2012 Sep; 12(9):1173-90. PubMed ID: 22650606 [TBL] [Abstract][Full Text] [Related]
5. Concepts of antibody-mediated cancer therapy. Kummer U; Staerz UD Cancer Invest; 1993; 11(2):174-84. PubMed ID: 8462018 [No Abstract] [Full Text] [Related]
6. Future prospects of monoclonal antibodies as magic bullets in immunotherapy. Maleki LA; Baradaran B; Majidi J; Mohammadian M; Shahneh FZ Hum Antibodies; 2013; 22(1-2):9-13. PubMed ID: 24284304 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody therapy of cancer. Jurcic JG; Scheinberg DA; Houghton AN Cancer Chemother Biol Response Modif; 1997; 17():195-216. PubMed ID: 9551215 [No Abstract] [Full Text] [Related]
8. Use of antibodies and immunoconjugates for the therapy of more accessible cancers. Sharkey RM; Goldenberg DM Adv Drug Deliv Rev; 2008 Sep; 60(12):1407-20. PubMed ID: 18508155 [TBL] [Abstract][Full Text] [Related]
9. [Antibody-conjugated cytostatic drugs. Uses of monoclonal antibodies for new strategies in tumor therapy]. Renner C; Pfreundschuh M Fortschr Med; 1994 Oct; 112(29):399. PubMed ID: 8001887 [No Abstract] [Full Text] [Related]
10. Progress in immunoconjugate cancer therapeutics. Payne G Cancer Cell; 2003 Mar; 3(3):207-12. PubMed ID: 12676579 [TBL] [Abstract][Full Text] [Related]
11. Immunoconjugates and immunotoxins for therapy of solid tumors. Hellström I; Trail P; Siegall C; Firestone R; Hellström KE Cancer Chemother Pharmacol; 1996; 38 Suppl():S35-6. PubMed ID: 8765413 [No Abstract] [Full Text] [Related]
13. Monoclonal antibody therapy for cancer. von Mehren M; Adams GP; Weiner LM Annu Rev Med; 2003; 54():343-69. PubMed ID: 12525678 [TBL] [Abstract][Full Text] [Related]
14. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody-based therapy strategies: providing options for the cancer patient. Milenic DE Curr Pharm Des; 2002; 8(19):1749-64. PubMed ID: 12171546 [TBL] [Abstract][Full Text] [Related]
16. [New developments in therapy of non-Hodgkin lymphomas with monoclonal antibodies]. Buske C; Feuring-Buske M; Unterhalt M; Hiddemann W Dtsch Med Wochenschr; 1999 Jul; 124(27):842-7. PubMed ID: 10432945 [No Abstract] [Full Text] [Related]
18. Hybridoma technology: the preferred method for monoclonal antibody generation for Zaroff S; Tan G Biotechniques; 2019 Sep; 67(3):90-92. PubMed ID: 31347924 [No Abstract] [Full Text] [Related]
19. Proceedings of the Eleventh Conference on Cancer Therapy with Antibodies and Immunoconjugates. October 12-14, 2006. Parsippany, New Jersey, USA. Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5499s-660s. PubMed ID: 18080348 [No Abstract] [Full Text] [Related]